蔚藍生物(603739.SH):就向生物製品增資已完成相關工商變更登記手續
格隆匯5月25日丨蔚藍生物(603739.SH)公佈,公司於2020年4月28日召開的第三屆董事會第十七次會議審議通過了《關於向全資子公司青島蔚藍生物製品有限公司增資的議案》。公司擬以自有資金向全資子公司青島蔚藍生物製品有限公司(“生物製品”)增加註冊資本4.3億元,此次增資完成後,生物製品的註冊資本將增至5億元,公司持有其100%股權。
近日,生物製品已完成相關工商變更登記手續,並取得青島高新技術產業開發區市場監督管理局換髮的營業執照,註冊資本5億元,經營範圍:生產:胚毒/細胞毒活疫苗、細菌活疫苗、胚毒滅活疫苗生產線、細胞毒滅活疫苗生產線、細菌滅活疫苗生產線、卵黃抗體生產線(獸藥生產許可證,有效期限以許可證為準)試驗區內獸用生物製品研究及飼料添加劑開發;畜牧獸醫技術服務及技術推廣,應用生物工程技術推廣;動物保健品及技術研製推廣(依法須經批准的項目,經相關部門批准後方可開展經營活動)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.